Acadia Pharmaceuticals Stock Performance

ACAD Stock  USD 24.56  0.08  0.32%   
The firm owns a Beta (Systematic Risk) of 0.62, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ACADIA Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding ACADIA Pharmaceuticals is expected to be smaller as well. ACADIA Pharmaceuticals at this moment owns a risk of 2.12%. Please confirm ACADIA Pharmaceuticals mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to decide if ACADIA Pharmaceuticals will be following its current price history.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days ACADIA Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, ACADIA Pharmaceuticals is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more

Actual Historical Performance (%)

One Day Return
(0.32)
Five Day Return
2.29
Year To Date Return
(6.58)
Ten Year Return
42.29
All Time Return
266.57
1
Stifel Maintains Hold Rating and Raises Price Target for ACAD to 25.00 ACAD Stock News - GuruFocus
12/11/2025
2
FTRE vs. ACAD Which Stock Is the Better Value Option
01/12/2026
3
Acadia Pharmaceuticals stock undervalued with 32 price target, says Canaccord - Investing.com Nigeria
01/27/2026
4
Guess which ASX 200 healthcare share is crashing 22 percent on Tuesday on European blow
02/02/2026
5
The Bull Case For ACADIA Pharmaceuticals Could Change Following EMA Setback For Trofinetide Approval
02/03/2026
6
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
02/04/2026
7
Disposition of 12944 shares by Rhodes Jennifer J of ACADIA Pharmaceuticals subject to Rule 16b-3
02/06/2026
8
Disposition of 6950 shares by Rhodes Jennifer J of ACADIA Pharmaceuticals at 23.38 subject to Rule 16b-3
02/09/2026
9
A Look At ACADIA Pharmaceuticals Valuation After Recent Share Price Weakness
02/12/2026
10
Oppenheimer Maintains A Balanced Outlook on ACADIA Pharmaceuticals Inc. For 2026
02/18/2026
11
Acadia Pharma Q4 2025 Earnings Preview
02/24/2026
Begin Period Cash Flow194.4 M
Total Cashflows From Investing Activities-30.5 M

ACADIA Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  2,485  in ACADIA Pharmaceuticals on November 30, 2025 and sell it today you would lose (29.00) from holding ACADIA Pharmaceuticals or give up 1.17% of portfolio value over 90 days. ACADIA Pharmaceuticals is currently generating 0.0027% in daily expected returns and assumes 2.1163% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than ACADIA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days ACADIA Pharmaceuticals is expected to generate 22.37 times less return on investment than the market. In addition to that, the company is 2.79 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

ACADIA Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of ACADIA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 24.56 90 days 24.56 
about 75.94
Based on a normal probability distribution, the odds of ACADIA Pharmaceuticals to move above the current price in 90 days from now is about 75.94 (This ACADIA Pharmaceuticals probability density function shows the probability of ACADIA Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days ACADIA Pharmaceuticals has a beta of 0.62. This suggests as returns on the market go up, ACADIA Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ACADIA Pharmaceuticals will be expected to be much smaller as well. Additionally ACADIA Pharmaceuticals has an alpha of 0.0244, implying that it can generate a 0.0244 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   ACADIA Pharmaceuticals Price Density   
       Price  

Predictive Modules for ACADIA Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ACADIA Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
22.4324.5526.67
Details
Intrinsic
Valuation
LowRealHigh
22.1028.2530.37
Details
Naive
Forecast
LowNextHigh
24.9127.0329.14
Details
20 Analysts
Consensus
LowTargetHigh
28.9431.8035.30
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ACADIA Pharmaceuticals. Your research has to be compared to or analyzed against ACADIA Pharmaceuticals' peers to derive any actionable benefits. When done correctly, ACADIA Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ACADIA Pharmaceuticals.

ACADIA Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ACADIA Pharmaceuticals is not an exception. The market had few large corrections towards the ACADIA Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ACADIA Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ACADIA Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.02
β
Beta against Dow Jones0.62
σ
Overall volatility
1.59
Ir
Information ratio -0.0028

ACADIA Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ACADIA Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ACADIA Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ACADIA Pharmaceuticals is unlikely to experience financial distress in the next 2 years
ACADIA Pharmaceuticals has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from seekingalpha.com: Acadia Pharma Q4 2025 Earnings Preview

ACADIA Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ACADIA Stock often depends not only on the future outlook of the current and potential ACADIA Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ACADIA Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding171.4 M
Cash And Short Term Investments819.7 M

ACADIA Pharmaceuticals Fundamentals Growth

ACADIA Stock prices reflect investors' perceptions of the future prospects and financial health of ACADIA Pharmaceuticals, and ACADIA Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ACADIA Stock performance.

About ACADIA Pharmaceuticals Performance

By analyzing ACADIA Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into ACADIA Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ACADIA Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ACADIA Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 142.19  195.60 
Return On Tangible Assets 0.27  0.28 
Return On Capital Employed 0.08  0.09 
Return On Assets 0.25  0.26 
Return On Equity 0.32  0.33 

Things to note about ACADIA Pharmaceuticals performance evaluation

Checking the ongoing alerts about ACADIA Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ACADIA Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ACADIA Pharmaceuticals is unlikely to experience financial distress in the next 2 years
ACADIA Pharmaceuticals has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from seekingalpha.com: Acadia Pharma Q4 2025 Earnings Preview
Evaluating ACADIA Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ACADIA Pharmaceuticals' stock performance include:
  • Analyzing ACADIA Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ACADIA Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining ACADIA Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ACADIA Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ACADIA Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ACADIA Pharmaceuticals' stock. These opinions can provide insight into ACADIA Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ACADIA Pharmaceuticals' stock performance is not an exact science, and many factors can impact ACADIA Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ACADIA Stock analysis

When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity